Cost‐effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)‐guided prostate biopsy prophylaxis

Abstract

As the risk of admission for infectious complications due to TRUSBx increases, use of an intensive prophylactic antibiotic regimen becomes significantly more cost-effective than current standard antibiotic prophylaxis.